-  This bill is not active in this session.
 
     
  •  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A00692 Summary:

BILL NOA00692
 
SAME ASSAME AS S00748
 
SPONSORRosenthal
 
COSPNSR
 
MLTSPNSR
 
Amd §§225 & 3000-c, Pub Health L; amd §3, Chap of 2024 (as proposed in S.1078-A & A.2885-A)
 
Makes technical changes to certain provisions requiring epinephrine auto-injector devices to be made available in places of public assembly; amends the effectiveness of such provisions.
Go to top

A00692 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                           692
 
                               2025-2026 Regular Sessions
 
                   IN ASSEMBLY
 
                                       (Prefiled)
 
                                     January 8, 2025
                                       ___________
 
        Introduced  by  M.  of  A.  ROSENTHAL  --  read once and referred to the
          Committee on Health
 
        AN ACT to amend the public health law, in relation to  making  technical
          changes  to  certain provisions of such law; and to amend a chapter of
          the laws of 2024 amending the public health law relating to  requiring
          that functional epinephrine auto-injector devices be made available in
          places  of public assembly and that at least one employee or volunteer
          of such place of public assembly be trained in  its  proper  operation
          and  use  and  be  present  at  each facility function, as proposed in
          legislative bills numbers S.  1078-A and A. 2885-A, in relation to the
          effectiveness thereof
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section 1. Subdivision 5-d of section 225 of the public health law, as
     2  added  by  a  chapter of the laws of 2024 amending the public health law
     3  relating to requiring that functional epinephrine auto-injector  devices
     4  be  made  available  in  places of public assembly and that at least one
     5  employee or volunteer of such place of public assembly be trained in its
     6  proper operation and use and be present at each  facility  function,  as
     7  proposed in legislative bills numbers S. 1078-A and A. 2885-A, is relet-
     8  tered subdivision 5-e.
     9    §  2.  Paragraph  (f) of subdivision 2 of section 3000-c of the public
    10  health law, as amended by a chapter of the laws  of  2024  amending  the
    11  public  health  law  relating  to  requiring that functional epinephrine
    12  auto-injector devices be made available in places of public assembly and
    13  that at least one employee or volunteer of such place of public assembly
    14  be trained in its proper operation and use and be present at each facil-
    15  ity function, as proposed in legislative bills numbers S. 1078-A and  A.
    16  2885-A, is amended to read as follows:
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02705-01-5

        A. 692                              2
 
     1    (f) Nothing in this section shall require any eligible person or enti-
     2  ty to acquire, possess, store, make available, or administer an epineph-
     3  rine  auto-injector,  except  as  provided  for  in subdivision [five-d]
     4  five-e of section two hundred twenty-five of this chapter.
     5    §  3.  Section  three  of  a  chapter of the laws of 2024 amending the
     6  public health law relating  to  requiring  that  functional  epinephrine
     7  auto-injector devices be made available in places of public assembly and
     8  that at least one employee or volunteer of such place of public assembly
     9  be trained in its proper operation and use and be present at each facil-
    10  ity  function, as proposed in legislative bills numbers S. 1078-A and A.
    11  2885-A, is amended to read as follows:
    12    § 3. This act shall take effect [immediately]  nine  months  after  it
    13  shall have become a law.  Effective immediately, the addition, amendment
    14  and/or repeal of any rule or regulation necessary for the implementation
    15  of  this  act  on  its  effective  date  are  authorized  to be made and
    16  completed on or before such effective date.
    17    § 4. This act shall take effect immediately; provided,  however,  that
    18  sections  one and two of this act shall take effect on the same date and
    19  in the same manner as a chapter of the laws of 2024 amending the  public
    20  health law relating to requiring that functional epinephrine auto-injec-
    21  tor  devices  be made available in places of public assembly and that at
    22  least one employee or volunteer of such  place  of  public  assembly  be
    23  trained  in its proper operation and use and be present at each facility
    24  function, as proposed in legislative bills  numbers  S.  1078-A  and  A.
    25  2885-A, takes effect.
Go to top